Picton Mahoney Asset Management’s MedTech Acquisition Corporation Unit MTACU Stock Holding History
Bought
Maintained
Sold
Other funds holding MTACU
MF
HP
DM
DCP
IM
MP
PVI
VI
MA
Picton Mahoney Asset Management's MTACU Position: Q1 2021 in Review
Picton Mahoney Asset Management sold out of MedTech Acquisition Corporation Unit (MTACU) in Q1 2021, closing a stake of 225,000 shares — an estimated $2.36M sold.
Picton Mahoney Asset Management first reported a position in MTACU in Q4 2020 and held it in 1 quarter. The position peaked at $2.36M in Q4 2020. 31 funds tracked by Wall St. Rank hold MTACU as of Q1 2021.
- Picton Mahoney Asset Management reported no remaining MedTech Acquisition Corporation Unit position as of Q1 2021 after selling out during the quarter.
- Picton Mahoney Asset Management sold 225,000 MedTech Acquisition Corporation Unit shares in Q1 2021, an estimated $2.36M.
- Picton Mahoney Asset Management first reported a position in MedTech Acquisition Corporation Unit in Q4 2020 and held it in 1 quarter.
- Picton Mahoney Asset Management's MedTech Acquisition Corporation Unit position peaked at $2.36M in Q4 2020.
- 31 funds tracked by Wall St. Rank held MedTech Acquisition Corporation Unit as of Q1 2021.
Based on Picton Mahoney Asset Management's 13F filing for Q1 2021, filed 4 May 2021.